(2026). Baseline vitamin D levels and progression-free survival in patients with HR+/HER2−metastatic breast cancer treated with ribociclib: A retrospective single-center analysis. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Baseline Vitamin D Levels and Progression-free Survival in Patients with HR+/HER2−metastatic Breast Cancer Treated with Ribociclib: A Retrospective Single-center Analysis."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Baseline Vitamin D Levels and Progression-free Survival in Patients with HR+/HER2−metastatic Breast Cancer Treated with Ribociclib: A Retrospective Single-center Analysis."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.